Cargando…
Efficacy, Safety, and Tolerability of Pregabalin Treatment for Painful Diabetic Peripheral Neuropathy: Findings from seven randomized, controlled trials across a range of doses
OBJECTIVE—To evaluate the efficacy, safety, and tolerability of pregabalin across the effective dosing range, to determine differences in the efficacy of three times daily (TID) versus twice daily (BID) dosage schedules, and to use time-to-event analysis to determine the time to onset of a sustained...
Autores principales: | Freeman, Roy, Durso-DeCruz, Edith, Emir, Birol |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
American Diabetes Association
2008
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2453685/ https://www.ncbi.nlm.nih.gov/pubmed/18356405 http://dx.doi.org/10.2337/dc07-2105 |
Ejemplares similares
-
Diabetic Neuropathies: Update on Definitions, Diagnostic Criteria, Estimation of Severity, and Treatments
por: Tesfaye, Solomon, et al.
Publicado: (2010) -
Cardiac Autonomic Neuropathy in Diabetes: A clinical perspective
por: Pop-Busui, Rodica
Publicado: (2010) -
Predictors of placebo response in peripheral neuropathic pain: insights from pregabalin clinical trials
por: Freeman, Roy, et al.
Publicado: (2015) -
Diabetes and Sepsis: Preclinical Findings and Clinical Relevance
por: Schuetz, Philipp, et al.
Publicado: (2011) -
Health Systems, Patients Factors, and Quality of Care for Diabetes: A synthesis of findings from the TRIAD Study
Publicado: (2010)